Market access in japan
Market Access, or the fourth hurdle, is a relatively new concept in Japan. One reasonfor this is that all pharmaceutical and medical device products approved by the Japan’s regulatory agency, the PMDA, were previously listed to NHI semi-automatically. However, with the steady increase in healthcare costs, pricing and reimbursement of drugs and medical devices has become a challenge. Well-prepared communication that demonstrate the benefits of your product help optimise your product’s market entry (market access).
our service
Healthcare to All (H2A) recommends conducting a market access research as a part of the launch plan. Traditional Market Access research and analysis, such as stakeholders mapping and reimbursement environment can help you understand all possible and prosible approaches and their impact on your business. As each country has a different healthcare structure, market access strategy must be tailored to the market and product.
Japan is the second biggest market for healthcare services and products and currently faces a rapidly changing access environment. This market was previously driven by medical doctors, but the dynamics of the market are constantly changing due to strained healthcare budget. These latest insights, along with advce from local experts, are included in our deliverables.
Finally, we provide market access strategies and realistic recommendations that fit your budget and schedule. We offer different levels of suggestions so that you can apply one that best fits your strategy.
project example
A Market Access research
Duration: approximately two months
Research method: desk researh (and interview TBD)
At the end of this project, you will know..:
Stakeholders and key drivers
Possible price and reimbursement coverage
Latest policy discussions
Market Access plan and next steps
Project delivery:
Kick off meeting, weekly meeting with Q&A sessions, and final presentation (to internal stakeholders upon request)
